PACIFIC MERCANTILE BANCORP Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of financial condition

In millions of USD, except per-share amounts

	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016
ASSETS
Cash and due from banks
Interest bearing deposits with financial institutions
Cash and cash equivalents
Interest-bearing time deposits with financial institutions
Federal Reserve Bank of San Francisco and Federal Home Loan Bank Stock, at cost
Securities available for sale, at fair value
Loans (net of allowances of $17,127 and $17,452, respectively)
Other real estate owned
Loans (net of allowances of $17,268 and $17,452, respectively)
Accrued interest receivable
Premises and equipment, net
Net deferred tax assets
Intangible assets
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Deposits:
Noninterest-bearing
Interest-bearing
Total deposits
Borrowings
Accrued interest payable
Other liabilities
Junior subordinated debentures
Total liabilities
Shareholders’ equity:
Series A Non-Voting Preferred Stock, no par value, 0 and 1,467,155 shares authorized at December 31, 2019 and December 31, 2018, respectively; 0 and 1,467,155 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively
Series B Convertible 8.4% Noncumulative Preferred Stock, 300,000 shares authorized; 0 issued and outstanding at December 31, 2016 and December 31, 2015; liquidation preference $100 per share, plus accumulated but undeclared dividends
Series C 8.4% Noncumulative Preferred Stock, 300,000 shares authorized; 0 issued and outstanding at December 31, 2016 and December 31, 2015; liquidation preference $100 per share plus accumulated but undeclared dividends
Total series A Non-Voting Preferred Stock, no par value, 0 and 1,467,155 shares authorized at December 31, 2019 and December 31, 2018, respectively; 0 and 1,467,155 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively

Common stock, no par value, 85,000,000 shares of voting common stock and 2,000,000 shares of non-voting common stock authorized; 22,423,625 and 22,191,260 voting shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively; 1,467,155 non-voting shares issued and outstanding at June 30, 2021 and December 31, 2020
Retained earnings
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments